Clinical Trials Browser

Phase 1/2 × Active not recruiting × capivasertib × Clear all

NCT03742102 2026-02-02

BEGONIA

Phase 1/2 Active not recruiting

243 enrolled 13 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01992952 2025-11-26

FAKTION

Phase 1/2 Active not recruiting

Estrogen Receptor Positive Breast Cancer